U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07443631) titled 'Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants' on Feb. 25.
Brief Summary: This is a randomized, controlled, open-label, 6 parallel arms study to assess reduced exposure of biomarkers of exposure (BoE) of selected HPHC in smokers switching to TP18 (a prototype heated tobacco device) or THS relative to smokers who continue smoking CIG after 5 days of confinement period, followed by 2 days of pharmacokinetic (PK) period of single use of THS/TP18 and CIG, and followed by an ambulatory period.
Study Start Date: Feb. 19
Study Type: INTERVENTIONAL
Condition:
Smoking
Intervention:
OTHER: T...